Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangrui Fan

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 26, 2024
Comparative study on the efficacy of low-dose and full-dose BCG bladder perfusion therapyChaohu Chen, Guangrui Fan, Pan Li, et al.
Translational Andrology and Urology|March 15, 2021
Association of TERT gene polymorphisms with clinical benign prostatic hyperplasia in a Chinese Han population of the Northwest regionGuangrui Fan, Kun Li, Yangyang Pang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 13, 2022
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancerRunchang Wang, Dongyang Gao, Chaohu Chen, et al.
Materials Today. Bio|March 19, 2025
Enhanced efficacy of immune checkpoint inhibitors by folate-targeted multifunctional drug through synergistic therapy inducing ferroptosis and immunogenic cell death in bladder cancerYibo Shi, Guangrui Fan, Enguang Yang, et al.
Free Radical Biology & Medicine|September 19, 2023
CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathwayDongyang Gao, Runchang Wang, Yuwen Gong, et al.
Bioorganic Chemistry|September 8, 2024
FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screeningGuangrui Fan, Xiongfei Luo, Yibo Shi, et al.
International Journal of Biological Sciences|April 20, 2026
TIMP1 Derived from Mesenchymal Stem Cells Promotes Bladder Cancer Progression by Regulating the Formation of VDIMs through the RAP1 PathwayPan Li, Enguang Yang, Xinyu Zhang, et al.
Journal of Nanobiotechnology|November 22, 2025
A novel sono-activatable nanoreactor induces precision intratumoral juglone generation and caspase 3/GSDME-mediated pyroptosis for treatment of bladder cancerYuanfeng Zhang, Enguang Yang, Xinyu Zhang, et al.
Communications Biology|January 10, 2025
SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathwayYuwen Gong, Dongyang Gao, Yibo Shi, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancerGuangrui Fan, Xiongfei Luo, Kun Li, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 26, 2024
Comparative study on the efficacy of low-dose and full-dose BCG bladder perfusion therapyChaohu Chen, Guangrui Fan, Pan Li, et al.
Translational Andrology and Urology|March 15, 2021
Association of TERT gene polymorphisms with clinical benign prostatic hyperplasia in a Chinese Han population of the Northwest regionGuangrui Fan, Kun Li, Yangyang Pang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 13, 2022
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancerRunchang Wang, Dongyang Gao, Chaohu Chen, et al.
Materials Today. Bio|March 19, 2025
Enhanced efficacy of immune checkpoint inhibitors by folate-targeted multifunctional drug through synergistic therapy inducing ferroptosis and immunogenic cell death in bladder cancerYibo Shi, Guangrui Fan, Enguang Yang, et al.
Free Radical Biology & Medicine|September 19, 2023
CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathwayDongyang Gao, Runchang Wang, Yuwen Gong, et al.
Bioorganic Chemistry|September 8, 2024
FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screeningGuangrui Fan, Xiongfei Luo, Yibo Shi, et al.
International Journal of Biological Sciences|April 20, 2026
TIMP1 Derived from Mesenchymal Stem Cells Promotes Bladder Cancer Progression by Regulating the Formation of VDIMs through the RAP1 PathwayPan Li, Enguang Yang, Xinyu Zhang, et al.
Journal of Nanobiotechnology|November 22, 2025
A novel sono-activatable nanoreactor induces precision intratumoral juglone generation and caspase 3/GSDME-mediated pyroptosis for treatment of bladder cancerYuanfeng Zhang, Enguang Yang, Xinyu Zhang, et al.
Communications Biology|January 10, 2025
SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathwayYuwen Gong, Dongyang Gao, Yibo Shi, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancerGuangrui Fan, Xiongfei Luo, Kun Li, et al.
Pageof 3